These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
151 related items for PubMed ID: 28406696
1. Proteomic approach for identification of IgA nephropathy-related biomarkers in urine. Prikryl P, Vojtova L, Maixnerova D, Vokurka M, Neprasova M, Zima T, Tesar V. Physiol Res; 2017 Sep 22; 66(4):621-632. PubMed ID: 28406696 [Abstract] [Full Text] [Related]
2. Analysis of the differential urinary protein profile in IgA nephropathy patients of Uygur ethnicity. Guo Z, Wang Z, Lu C, Yang S, Sun H, Reziw, Guo Y, Sun W, Yue H. BMC Nephrol; 2018 Dec 14; 19(1):358. PubMed ID: 30547763 [Abstract] [Full Text] [Related]
3. Urinary complement proteins in IgA nephropathy progression from a relative quantitative proteomic analysis. Niu X, Zhang S, Shao C, Guo Z, Wu J, Tao J, Zheng K, Ye W, Cai G, Sun W, Li M. PeerJ; 2023 Dec 14; 11():e15125. PubMed ID: 37065697 [Abstract] [Full Text] [Related]
4. Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy. Moon PG, Lee JE, You S, Kim TK, Cho JH, Kim IS, Kwon TH, Kim CD, Park SH, Hwang D, Kim YL, Baek MC. Proteomics; 2011 Jun 14; 11(12):2459-75. PubMed ID: 21595033 [Abstract] [Full Text] [Related]
5. Complement components, proteolysis‑related, and cell communication‑related proteins detected in urine proteomics are associated with IgA nephropathy. Mucha K, Bakun M, Jaźwiec R, Dadlez M, Florczak M, Bajor M, Gala K, Pączek L. Pol Arch Med Wewn; 2014 Jun 14; 124(7-8):380-6. PubMed ID: 24938435 [Abstract] [Full Text] [Related]
6. Poor histological lesions in IgA nephropathy may be reflected in blood and urine peptide profiling. Graterol F, Navarro-Muñoz M, Ibernon M, López D, Troya MI, Pérez V, Bonet J, Romero R. BMC Nephrol; 2013 Apr 11; 14():82. PubMed ID: 23577616 [Abstract] [Full Text] [Related]
7. LG3 fragment of endorepellin is a possible biomarker of severity in IgA nephropathy. Surin B, Sachon E, Rougier JP, Steverlynck C, Garreau C, Lelongt B, Ronco P, Piedagnel R. Proteomics; 2013 Jan 11; 13(1):142-52. PubMed ID: 23161552 [Abstract] [Full Text] [Related]
8. Application of Sparse Linear Discriminant Analysis and Elastic Net for Diagnosis of IgA Nephropathy: Statistical and Biological Viewpoints. Mohammadi Majd T, Kalantari S, Raeisi Shahraki H, Nafar M, Almasi A, Samavat S, Parvin M, Hashemian A. Iran Biomed J; 2018 Nov 11; 22(6):374-84. PubMed ID: 29523019 [Abstract] [Full Text] [Related]
9. Urinary prognostic biomarkers and classification of IgA nephropathy by high resolution mass spectrometry coupled with liquid chromatography. Kalantari S, Rutishauser D, Samavat S, Nafar M, Mahmudieh L, Rezaei-Tavirani M, Zubarev RA. PLoS One; 2013 Nov 11; 8(12):e80830. PubMed ID: 24339887 [Abstract] [Full Text] [Related]
10. Urinary proteome analysis by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry with magnetic beads for identifying the pathologic presentation of clinical early IgA nephropathy. He Q, Shao L, Yu J, Ji S, Wang H, Mao Y, Chen J. J Biomed Nanotechnol; 2012 Feb 11; 8(1):133-9. PubMed ID: 22515101 [Abstract] [Full Text] [Related]
11. Toward Noninvasive Diagnosis of IgA Nephropathy: A Pilot Urinary Metabolomic and Proteomic Study. Neprasova M, Maixnerova D, Novak J, Reily C, Julian BA, Boron J, Novotny P, Suchanek M, Tesar V, Kacer P. Dis Markers; 2016 Feb 11; 2016():3650909. PubMed ID: 27799660 [Abstract] [Full Text] [Related]
12. Noninvasive Urinary Monitoring of Progression in IgA Nephropathy. Yang JYC, Sarwal RD, Fervenza FC, Sarwal MM, Lafayette RA. Int J Mol Sci; 2019 Sep 10; 20(18):. PubMed ID: 31510053 [Abstract] [Full Text] [Related]
13. Establishment of a 2-D human urinary proteomic map in IgA nephropathy. Park MR, Wang EH, Jin DC, Cha JH, Lee KH, Yang CW, Kang CS, Choi YJ. Proteomics; 2006 Feb 10; 6(3):1066-76. PubMed ID: 16372274 [Abstract] [Full Text] [Related]
14. Comparative proteomic analysis of urine and laser microdissected glomeruli in IgA nephropathy. Ning X, Yin Z, Li Z, Xu J, Wang L, Shen W, Lu Y, Cai G, Zhang X, Chen X. Clin Exp Pharmacol Physiol; 2017 May 10; 44(5):576-585. PubMed ID: 28109170 [Abstract] [Full Text] [Related]
15. Matrix-assisted laser desorption/ionization mass spectrometry imaging to uncover protein alterations associated with the progression of IgA nephropathy. Ivanova M, Dyadyk O, Ivanov D, Clerici F, Smith A, Magni F. Virchows Arch; 2020 Jun 10; 476(6):903-914. PubMed ID: 31838587 [Abstract] [Full Text] [Related]
16. Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy. Haubitz M, Wittke S, Weissinger EM, Walden M, Rupprecht HD, Floege J, Haller H, Mischak H. Kidney Int; 2005 Jun 10; 67(6):2313-20. PubMed ID: 15882273 [Abstract] [Full Text] [Related]
17. Candidate Urine Peptide Biomarkers for IgA Nephropathy: Where Are We Now? Marek-Bukowiec K, Konieczny A, Ratajczyk K, Witkiewicz W. Dis Markers; 2018 Jun 10; 2018():5205831. PubMed ID: 29606986 [Abstract] [Full Text] [Related]
18. Identification of a uromodulin fragment for diagnosis of IgA nephropathy. Wu J, Wang N, Wang J, Xie Y, Li Y, Liang T, Wang J, Yin Z, He K, Chen X. Rapid Commun Mass Spectrom; 2010 Jul 30; 24(14):1971-8. PubMed ID: 20552702 [Abstract] [Full Text] [Related]
19. Diagnostic urinary proteome profile for immunoglobulin a nephropathy. Samavat S, Kalantari S, Nafar M, Rutishauser D, Rezaei-Tavirani M, Parvin M, Zubarev RA. Iran J Kidney Dis; 2015 May 30; 9(3):239-48. PubMed ID: 25957429 [Abstract] [Full Text] [Related]
20. Urine podocyte mRNAs mark disease activity in IgA nephropathy. Fukuda A, Sato Y, Iwakiri T, Komatsu H, Kikuchi M, Kitamura K, Wiggins RC, Fujimoto S. Nephrol Dial Transplant; 2015 Jul 30; 30(7):1140-50. PubMed ID: 25956757 [Abstract] [Full Text] [Related] Page: [Next] [New Search]